Classification of BC is primarily based on the expression of key signaling molecules including receptors for the female sex hormones (HR) estrogen and progesterone (ER, PR), as well as the human epidermal growth factor 2 (HER2). The gene discussed is ERBB2; the disease is breast cancer.